Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Periarticular Penetration of Cefazolin and Clindamycin in Second Stage Revision Arthroplasty of the Hip

NCT05421312 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT05421312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05421312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Periarticular Penetration of Cefazolin and Clindamycin in Second Stage Revision Arthroplasty of the Hip
Lead sponsor
Radboud University Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2022
Completion date
December 31, 2023
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bone and joint infection, pharmacokinetics, pji